Previous close | 0.0500 |
Open | N/A |
Bid | 0.0000 |
Ask | 0.4000 |
Strike | 7.50 |
Expiry date | 2024-05-17 |
Day's range | 0.0500 - 0.0500 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Q1 2024 Singular Genomics Systems Inc Earnings Call
Amidst financial pressures, Singular Genomics Systems Inc (OMIC) showcases strategic advancements and robust demand for its innovative G4 X spatial sequencer.
SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the first quarter ended March 31, 2024. “The first quarter was productive and encouraging. We are focused on supporting our existing customers and getting the G4X spatial sequencer to market